ArticleFrontiers in oncology2025

Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease.

Ziad Abuhelwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.